Actonel

A Bad Break: FDA Continues Review Of Bone Drugs

4 Comments

By Ed Silverman // March 11th, 2010 // 8:42 am

Procter & Gamble May Sell Its Pharma Business

1 Comment

By Ed Silverman // December 11th, 2008 // 1:04 pm

Osteoporosis Drugs Do Not Pose Heart Risk: FDA

Make a comment

By Ed Silverman // November 12th, 2008 // 1:50 pm

Amgen’s Osteoporosis Drug: Make Or Break

1 Comment

By Ed Silverman // September 12th, 2008 // 5:02 pm

Clear

Clear

All rights reserved, Nojasa LLC. Copyright, Nojasa LLC.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/